Advertisement

Integrity in International Stem Cell Research Collaborations

Science18 Aug 2006Vol 313, Issue 5789pp. 921-922DOI: 10.1126/science.1127990
Get full access to this article

View all available purchase options and get full access to this article.

Already a Subscriber?

Supplementary Material

File (mathews.som.pdf)

References and Notes

2.
Hansen B., Med. Law23, 19 (2004).
3.
Wilmut I., et al., Science310, 1903 (2005).
4.
Public database (http://www.hinxtongroup.org/) in design stage.
5.
U.K.'s Human Fertilisation and Embryology Authority (http://www.hfea.gov.uk/).
6.
U.S. National Academy of Sciences (http://dels.nas.edu/bls/stemcells/).
7.
International hESCR Guidelines Task Force of the International Society for Stem Cell Research (www.isscr.org/scientists/guidelines.cfm).
8.
International Stem Cell Forum (www.stemcellforum.org/).
9.
(1992), p. 1990Country-specific sources that formed the basis for the table were as follows. Australia: Human Cloning Prohibition Act (2002); Research Involving Human Embryos Act (2002); National Health & Medical Research Council's Ethical Guidelines on the Use of Assisted Reproductive Technology in Clinical Practice and Research. China: Ethical Guiding Principles for Research on Human Embryonic Stem Cells (2003); The Guidelines on Human Assisted Reproductive Technology (July 2003), promulgated by the Ministry of Health. United Kingdom: Human Fertilisation and Embryology Act, Schedules 2 and 3; Human Fertilisation and Embryology (Disclosure of Information) Act(; Human Fertilisation and Embryology (Research Purposes) Regulations (2001). Germany: StGB (German Penal Code); Embryonenschutzgesetz—ESchG(1990; Stammzellgesetz—StZG (2002). Israel: Prohibition of Genetic Intervention (Human Cloning and Genetic Manipulation of Reproductive Cells) Law, 5759-1999 (this law was renewed, and slightly amended, in 2004, with the same sunset clause established for another 5 years); Report of the Bioethics Advisory Committee of the Israel Academy of Sciences and Humanities: The Use of Embryonic Stem Cells for Therapeutic Research (2001); Public Health Regulations (1979).
10.
Supported by the Greenwall Foundation; the Wellcome Trust; the British Embassy in Washington, DC; and the Juvenile Diabetes Research Foundation.
Supporting Online Material

Information & Authors

Information

Published In

Science
Volume 313 | Issue 5789
18 August 2006

Submission history

Published in print: 18 August 2006

Permissions

Request permissions for this article.

Authors

Affiliations

Debra J. H. Mathews*
Phoebe R. Berman Bioethics Institute, The Johns Hopkins University, Baltimore, MD 21205, USA.
Peter Donovan
Stem Cell Research Center, University of California, Irvine, CA 92697, USA.
John Harris
Institute of Medicine, Law, and Bioethics, University of Manchester, Manchester M13 9PL, UK.
Robin Lovell-Badge
Division of Developmental Genetics, Medical Research Council (MRC) National Institute for Medical Research, London NW7 1AA, UK.
Julian Savulescu
Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford OX1 1P, UK.
Ruth Faden
Phoebe R. Berman Bioethics Institute, The Johns Hopkins University, Baltimore, MD 21205, USA.

Notes

*Author for correspondence. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage
Altmetrics

Citations

Export citation

Select the format you want to export the citation of this publication.

Cited by
  1. Yesterday’s Child: How Gene Editing for Enhancement Will Produce Obsolescence—and Why It Matters, The American Journal of Bioethics, 19, 7, (6-15), (2019).https://doi.org/10.1080/15265161.2019.1618943
    Crossref
  2. How and Why to Replace the 14-Day Rule, Current Stem Cell Reports, 4, 3, (228-234), (2018).https://doi.org/10.1007/s40778-018-0135-7
    Crossref
  3. Research Translation and Emerging Health Technologies: Synthetic Biology and Beyond, Health Care Analysis, 26, 4, (310-325), (2016).https://doi.org/10.1007/s10728-016-0334-2
    Crossref
  4. Outreach and Engagement: Evolving Media and the Public Obligations of Stem Cell Science, Current Stem Cell Reports, 1, 4, (219-226), (2015).https://doi.org/10.1007/s40778-015-0023-3
    Crossref
  5. Who Cares about Consent Requirements for Sourcing Human Embryonic Stem Cells? Are Errors In the Past Really Errors Of the Past? , Accountability in Research, 18, 4, (250-288), (2011).https://doi.org/10.1080/08989621.2011.584763
    Crossref
  6. Proprietary Interests and Collaboration in Stem Cell Science: Avoiding Anticommons, Countering Canalyzation, Translational Stem Cell Research, (267-284), (2011).https://doi.org/10.1007/978-1-60761-959-8_21
    Crossref
  7. Policy Uncertainty and the Conduct of Stem Cell Research, Cell Stem Cell, 8, 2, (132-135), (2011).https://doi.org/10.1016/j.stem.2011.01.002
    Crossref
  8. Policy Interoperability in Stem Cell Research: Demystifying Harmonization, Stem Cell Reviews and Reports, 5, 2, (108-115), (2009).https://doi.org/10.1007/s12015-009-9067-z
    Crossref
  9. Importing Human Pluripotent Stem Cell Lines Derived at Another Institution: Tailoring Review to Ethical Concerns, Cell Stem Cell, 4, 2, (115-123), (2009).https://doi.org/10.1016/j.stem.2009.01.013
    Crossref
  10. Two Models of Commercializing Stem Cell Science: Creating Conditions for Collaboration?, SSRN Electronic Journal, (2009).https://doi.org/10.2139/ssrn.1437690
    Crossref
Loading...

View Options

Get Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.
More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media